Cite

HARVARD Citation

    Nakai, Y. et al. (2021). Efficacy and safety of second-line axitinib in octogenarians with metastatic renal cell carcinoma. Journal of geriatric oncology. 12 (5), pp. 834-837. [Online]. 
  
Back to record